<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - Cambridge (Massachusetts)</title>
    <link>http://www.newstin.com/us/CAMBRIDGE_MASSACHUSETTS</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Alum gives Harvard $125 million</title>
      <link>http://www.newstin.com/tag/us/79884605</link>
      <description>Alum, now biomed executive, earmarks it for bioengineering institute MSNBC staff and news service reports CAMBRIDGE, Mass. - A Harvard Business School alumnus has given the university its largest individual donation ever — $125...</description>
      <pubDate>Tue, 07 Oct 2008 21:39:28 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79884605</guid>
      <dc:date>2008-10-07T21:39:28Z</dc:date>
    </item>
    <item>
      <title>Ariad Appoints Two New Members to Its Board of Directors (Business Wire)</title>
      <link>http://www.newstin.com/tag/us/79749020</link>
      <description>Tuesday October 7, 7:30 am ET CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA - Dr. Radaelli is the President and Chief Executive Officer of Dompé International SA, the international pharmaceutical...</description>
      <pubDate>Tue, 07 Oct 2008 12:09:57 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79749020</guid>
      <dc:date>2008-10-07T12:09:57Z</dc:date>
    </item>
    <item>
      <title>Helicos Ships Genetic Analysis System To Stanford University</title>
      <link>http://www.newstin.com/tag/us/79864938</link>
      <description>Helicos Ships Genetic Analysis System To Stanford UniversityCAMBRIDGE, Mass.MA-HELICOS-BIOSCIENCES CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Helicos BioSciences Corporation (NASDAQ:HLCS) today announced the shipment of a Helicos'...</description>
      <pubDate>Tue, 07 Oct 2008 18:37:43 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79864938</guid>
      <dc:date>2008-10-07T18:37:43Z</dc:date>
    </item>
    <item>
      <title>Web 2.0, Web 3.0 mashup to yield more personalized online experience</title>
      <link>http://www.newstin.com/tag/us/79813862</link>
      <description>CAMBRIDGE, Mass. -- While many enterprise firms are still searching for ways to wrap their minds -- and business models -- around Web 2.0 innovations such as and blogs, forward-thinking Web architects are already looking ahead...</description>
      <pubDate>Tue, 07 Oct 2008 13:45:20 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79813862</guid>
      <dc:date>2008-10-07T13:45:20Z</dc:date>
    </item>
    <item>
      <title>Basis Technology Powers Mark Logic Entity Enrichment</title>
      <link>http://www.newstin.com/tag/us/79838588</link>
      <description>CAMBRIDGE, Mass. --(Business Wire)-- Basis Technology Corp. (www.BasisTech.com) announced today that Mark Logic has licensed its Rosette Entity Extractor (REX) for thirteen languages to enrich the XML of a document by locating...</description>
      <pubDate>Tue, 07 Oct 2008 12:55:35 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79838588</guid>
      <dc:date>2008-10-07T12:55:35Z</dc:date>
    </item>
    <item>
      <title>In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International...</title>
      <link>http://www.newstin.com/tag/us/79754158</link>
      <description>In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop CAMBRIDGE, Mass., Oct. 7 /PRNewswire/ -- Taligen Therapeutics Inc. today announced that in vivo data on several...</description>
      <pubDate>Tue, 07 Oct 2008 12:00:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79754158</guid>
      <dc:date>2008-10-07T12:00:00Z</dc:date>
    </item>
    <item>
      <title>PowerSteering Announces Strong Q3 Sales Performance (Business Wire)</title>
      <link>http://www.newstin.com/tag/us/79830324</link>
      <description>CAMBRIDGE, Mass.----PowerSteering, the only On-Demand, Enterprise PPM software used to manage Information Technology, Six Sigma, New Product Development and other enterprise initiatives, today reported strong third quarter...</description>
      <pubDate>Tue, 07 Oct 2008 16:12:43 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79830324</guid>
      <dc:date>2008-10-07T16:12:43Z</dc:date>
    </item>
    <item>
      <title>Investing in risk assessment</title>
      <link>http://www.newstin.com/tag/us/79804536</link>
      <description>Between hurricanes, elections and the nation's economic crisis, Congress' plate has been full this fall, and reauthorization of the National Nanotechnology Initiative, which passed the House by a large margin in June, will be...</description>
      <pubDate>Tue, 07 Oct 2008 14:23:38 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79804536</guid>
      <dc:date>2008-10-07T14:23:38Z</dc:date>
    </item>
    <item>
      <title>Alum gives Harvard $125M for bioengineering center</title>
      <link>http://www.newstin.com/tag/us/79857844</link>
      <description>Alum gives Harvard $125M for bioengineering center October 7, 2008 - 3:03pm CAMBRIDGE, Mass. (AP) - A business school alumnus has given Harvard University its largest individual donation ever _ $125 million to start a...</description>
      <pubDate>Tue, 07 Oct 2008 19:04:10 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79857844</guid>
      <dc:date>2008-10-07T19:04:10Z</dc:date>
    </item>
    <item>
      <title>Verenium Appoints Gregory Powers Executive Vice President of Research and Development</title>
      <link>http://www.newstin.com/tag/us/79754466</link>
      <description>CAMBRIDGE, Mass., Oct. 7 /PRNewswire-FirstCall/ -- Verenium Corporation , a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced the appointment of Gregory...</description>
      <pubDate>Tue, 07 Oct 2008 12:25:52 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79754466</guid>
      <dc:date>2008-10-07T12:25:52Z</dc:date>
    </item>
  </channel>
</rss>

